HWAM
VIR icon

Hennion & Walsh Asset Management’s Vir Biotechnology VIR Stock Holding History

Hennion & Walsh Asset Management’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-35,132
Closed -$263K – 912
2024
Q3 		$263K Sell
35,132
-3,690
-10% -$32.1K 0.01% 776
2024
Q2 		$346K Sell
38,822
-328
-0.8% -$3.15K 0.02% 693
2024
Q1 		$397K Buy
39,150
+4,917
+14% +$50.1K 0.02% 627
2023
Q4 		$344K Sell
34,233
-479
-1% -$4.38K 0.02% 648
2023
Q3 		$325K Buy
34,712
+2,504
+8% +$35.7K 0.02% 631
2023
Q2 		$790K Buy
32,208
+635
+2% +$15.9K 0.05% 417
2023
Q1 		$735K Buy
31,573
+5,358
+20% +$137K 0.05% 425
2022
Q4 		$664K Buy
+26,215
New +$643K 0.04% 432

Other funds holding VIR

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return